J3399 Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes
Short descriptor: Inj onase abepar-xioi treat
Look up J3399 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
J3399 is the HCPCS Level II code for Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.
Classification & CMS Attributes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Drugs (indicator 51)
- Type of Service
- Medical care
- Effective Date
- 2024-01-01
- 2026 Maintenance
- No change this year
Drug Details
- Drug / Substance
- onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes
- Route
- Injection
See the full HCPCS Table of Drugs (J-codes).
References
Cite This Page
Reference J3399 with the canonical source and edition:
J3399 — Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J3399
Canonical URL: https://icd10codingpro.com/hcpcs-codes/J3399